Provided by Tiger Fintech (Singapore) Pte. Ltd.

Miragen Therapeutics, Inc.

23.01
0.0000
Volume:- -
Turnover:- -
Market Cap:89.93M
PE:-2.38
High:23.01
Open:23.01
Low:23.01
Close:23.01
Loading ...
Feb 19, 2020

Major Issues Report

Current report, item 5.02
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Feb 06, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Jan 30, 2020

Major Issues Report

Current report, item 8.01
Dec 11, 2019

Major Issues Report

Current report, items 1.01, 1.02, 2.05, 5.02, 7.01, 8.01, and 9.01
Nov 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Oct 31, 2019

Major Issues Report

Current report, items 1.01, 3.01, 3.02, and 9.01
Oct 16, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 08, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 07, 2019

Major Issues Report

Current report, items 1.02, 2.02, 2.05, and 9.01
Jul 19, 2019

Major Issues Report

Current report, item 5.02
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 21, 2019

Major Issues Report

Current report, item 5.07